Cargando…
Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
Cystic fibrosis (CF) is the most common genetic disorder among Caucasians, estimated to affect more than 70,000 people in the world. Severe and persistent bronchial inflammation and chronic bacterial infection, along with airway mucus obstruction, are hallmarks of CF lung disease and participate in...
Autores principales: | Mitri, Christie, Xu, Zhengzhong, Bardin, Pauline, Corvol, Harriet, Touqui, Lhousseine, Tabary, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396676/ https://www.ncbi.nlm.nih.gov/pubmed/32848733 http://dx.doi.org/10.3389/fphar.2020.01096 |
Ejemplares similares
-
Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018) -
TMEM16A/ANO1: Current Strategies and Novel Drug Approaches for Cystic Fibrosis
por: Mitri, Christie, et al.
Publicado: (2021) -
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
por: Plocque, Alexia, et al.
Publicado: (2022) -
miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2019) -
Expression and Roles of Antimicrobial Peptides in Innate Defense of Airway Mucosa: Potential Implication in Cystic Fibrosis
por: Geitani, Regina, et al.
Publicado: (2020)